Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGCHIX:MEDXZ +1.97%66 EV-to-FCF is 20.71 as of Jul. 31, 2026, which is 25% below its 10-year median of 27.77. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review. Among 1,725 Industrial Products companies, Medmix AG ranks better than 56.52% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medmix AG's Enterprise Value is CHF565.3 Mil.
Medmix AG's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was CHF27.3 Mil. Therefore, Medmix AG's EV-to-FCF for today is 20.71.
The historical rank and industry rank for Medmix AG's EV-to-FCF or its related term are showing as below:
CHIX:MEDXz'
s EV-to-FCF Range Over the Past 10 Years
Min: 13.97 Med: 27.77 Max: 315.02
Current: 20.71
During the past 8 years, the highest EV-to-FCF of Medmix AG was 315.02. The lowest was 13.97. And the median was 27.77.
CHIX:MEDXz's EV-to-FCF is ranked better than 56.52% of 1725
companies
in the Industrial Products industry
Industry Median: 23.71
vs CHIX:MEDXz: 20.71
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medmix AG's share price for today is CHF8.535.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was CHF0.150.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medmix AG EV-to-FCF Related Terms
Medmix AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Medmix AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Medmix AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG EV-to-FCF vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medmix AG's EV-to-FCF falls into.
Medmix AG's current Enterprise Value is CHF565.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was CHF27.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (CHIX:MEDXZ) has a EV-to-FCF of 20.71 as of Jul. 31, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medmix AG and its competitors. This is 25% below median its historical median of 27.77. Over the past decade, Medmix AG's EV-to-FCF has ranged from 13.97 to 315.02. According to the industry distribution chart, Medmix AG ranks #750 out of 1725 companies in the Industrial Products industry, placing it in the top 43.5%.
Is Medmix AG's EV-to-FCF too high?
Medmix AG's current EV-to-FCF of 20.71 is 25% below median its 10-year median of 27.77. Over the past 10 years, this metric has ranged from a low of 13.97 to a high of 315.02. The Industrial Products industry median EV-to-FCF is 23.71. Medmix AG's value of 20.71 is 12.7% below this industry median. Based on the distribution chart, Medmix AG ranks #750 out of 1725 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's EV-to-FCF compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #750 out of 1725 companies for EV-to-FCF. This puts Medmix AG in the upper half of its industry. The industry median EV-to-FCF is 23.71. Medmix AG's value of 20.71 is 12.7% below this benchmark. Historically, Medmix AG's own EV-to-FCF has ranged from 13.97 to 315.02 over the past decade. While the company's 10-year median is 27.77 vs. the industry median of 23.71, Medmix AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for an Industrial Products company?
The median EV-to-FCF among Industrial Products companies is 23.71, based on 1,725 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current EV-to-FCF of 20.71 is 12.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median EV-to-FCF is 23.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current EV-to-FCF is 20.71, which is 25% below median its own 10-year median of 27.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current EV-to-FCF is 20.71, which is 25% below median its 10-year median of 27.77 and 12.7% below the Industrial Products industry median of 23.71. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current EV-to-FCF is 20.71 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for CHIX:MEDXZ:
EV-to-FCF: 20.71 (25% below median its 10-year median of 27.77)
GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
Industry Position: 12.7% below the Industrial Products median (#750 of 1725)
No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score
Get the complete analysis for CHIX:MEDXZ
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MEDXZ has been successfully added to your 
